|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
SmartPill Diagnostics, Inc. Capsule Clinical Trials Are Set To Begin At The University of Louisville
10/19/2005 5:10:11 PM
BUFFALO, N.Y.--(BUSINESS WIRE)--May 12, 2005--The SmartPill Corporation (www.smartpillcorp.com), developer of the SmartPill Capsule, an ingestible medical device that captures biomedical data from within a patient's GI tract, today announced that clinical trials of its SmartPill ACT-I Capsule and GI Monitoring System are expected to begin the week of May 23rd at the University of Louisville (Louisville, KY), bringing to five the number of sites participating in SmartPill clinical trials.
A total of 20 subjects, 14 Normals and six Gastroparetics, are expected to participate in the clinical research study. The principal investigator is John M. Wo, M.D., Associate Professor and Director of the Swallowing and Motility Center, and of the Clinical Research Unit, University of Louisville Department of Medicine, Division of Gastroenterology/Hepatology. The primary objective of the study is to demonstrate the correlation of gastric residence times measured by the SmartPill ACT-I Capsule and conventional scintigraphy.
|
|
|
|
|
|
|
|
|
|
|